November 2009 Company Updates and Additions

Ablynx Abraxis BioScience Abraxis Health Accuray Alder Biopharmaceuticals Ambrilia Biopharma Ambrx America Stem Cell (ASC) Astex Therapeutics AvidBiotics BioVex Bostwick Laboratories Cannasat Therapeutics Celera Chelsea Therapeutics Cornerstone Pharmaceuticals Covidien Delcath Systems Delphinus Medical Technologies DxS Echo Therapeutics Elara Pharmaceuticals Eli Lilly Enzon Pharmaceuticals Epizyme Evotec Excelimmune Flamel Technologies Flexion Therapeutics Genmab Gentium Gloucester Pharmaceuticals GTx Hologic HUYA Bioscience International Inostics InteRNA Technologies IRIS International Kotinos Pharmaceuticals Kun Run Biotechnology Life Technologies Ligon Discovery

Manhattan Scientifics Medical Therapies Merck Minster Pharmaceuticals Mirna Therapeutics Myriad Genetics Myriad Pharmaceuticals NeurogesX NewLink Genetics NKT Therapeutics (NKTT) Novexel NOXXON Pharma NuView Life Sciences Ohr Pharmaceutical On-Q-ity (OnQity) OPKO Health Osiris Therapeutics Paloma Pharmaceuticals Peplin Percipio Biotherapeutics PHusis Therapeutics QIAGEN ratiopharm Regeneron Pharmaceuticals RXi Pharmaceuticals Santaris Pharma Seattle Genetics Senesco Technologies Sequenom Sorrento Therapeutics (STI) Sunshine Biopharma TechniScan ThromboGenics Trimira TRIN Pharma Trius Therapeutics UCB Group Vermillion Xanodyne Pharmaceuticals Xoma Zosano Pharma Zyngenia